ABSTRACT
RACIONAL: O câncer gástrico continua sendo objeto de grande número de estudos que tentam entender melhor sua gênese, e conseqüentemente propor novos tratamentos. Na atualidade destaque especial está sendo dado na marcação imunoistoquímica onde estão sendo utilizados marcadores diversos sem se saber ainda qual ou quais são os mais efetivos no diagnóstico. OBJETIVO: Identificar e quantificar por citometria de imagem a expressão dos marcadores de angiogênese Fator VIII e CD-34 em tumores gástricos. MÉTODOS:Foram utilizados 29 casos de adenocarcinomas gástricos, todos oriundos de material arquivado e conservado em blocos de parafina. Após a desparafinização, realizou-se coloração com marcadores imunoistoquímicos de angiogênese Fator VIII e CD-34, e as lâminas coradas foram submetidas a estudo citofotométrico de imagem em sistema informatizado SAMBA 4000. RESULTADOS: Foram comparados os dois parâmetros oferecidos pelo método, índice de marcagem e densidade óptica, apenas nos 17 casos em que ocorreu identificação de ambos marcadores. Observou-se expressão numericamente significativa de ambos, porém o Fator VIII apresentou melhor média de densidade óptica, enquanto o CD-34 melhor resultado quanto ao índice de marcagem. CONCLUSÃO:A citometria de imagem foi capaz de identificar e quantificar a expressão do Fator VIII e CD-34 de maneira confiável e satisfatória demonstrando presença de angiogênese, sendo que o Fator VIII marcou menores áreas com melhor qualidade e o CD-34 marcou maiores áreas com menor qualidade.
BACKGROUND: Gastric cancer remains a subject of great interest in several studies searching for understanding its genesis and, therefore, proposing new treatments. Currently special credits have been given to immunohistochemistry as various markers are being tested with uncertain efficacy on diagnosis. AIM: To identify and quantify the expression of Factor VIII and CD-34, angiogenesis markers, in gastric tumors by imaging cytometry. METHODS: Twenty-nine 29 gastric adenocarcinomas sampled-tissue in paraffin blocks underwent immunohistochemical angiogenesis markers evaluation for factor VIII and CD-34 and the marked slides were submitted to SAMBA 4000 reading. RESULTS:The investigation method offered two comparison parameters, marking index and optical density, showing up both in 17 cases. Significant numerical expression had been observed for both markers, but Factor VIII showed a better optical density average while CD-34 presented a better result for marking index. CONCLUSIONS: Image cytometry identified and quantified Factor VIII and CD-34 expressions in a reliable and satisfactory manner, revealing the presence of angiogenesis. Factor VIII enhanced in smaller areas with better quality while CD-34 enhanced greater areas with lower quality.
ABSTRACT
Objectives: To clarify whether di (2-ethylhexyl) phthalate (DEHP) has immunotoxic effects on both the expression of surface molecules (CD3, CD4, CD8 and CD28) on T cells of the thymus and spleen in male C57BL/6 mice. Methods: Animals were orally administered a 0.1% or 0.2% DEHP-containing diet for 10 or 20 days. Dietary corn oil was used as the vehicle for DEHP in preparing the diet. Results: Significant hepatic hypertrophy was clearly observed in the DEHP-exposed groups, while no atrophy was seen in the thymus or spleen in any treatment groups. In the thymus and spleen, no variation in the proportions of both T cells expressing CD3, CD4 and CD8 was shown with cytometry analysis. The surface expression of CD3, CD4, CD8 and CD28 on both T cells was also invariable in all analyzed stages of thymic differentiation and in the spleen. No effect of DEHP on mitogenesis was shown in the splenic T cells with an in vitro [3H]-thymidine-incorporation technique. Conclusions: DEHP is probably not an immunosuppressor, particularly for T cells.
Subject(s)
T-Lymphocytes , Diethylhexyl Phthalate , Spleen , CD3 ComplexABSTRACT
<p><b>OBJECTIVES</b>To clarify whether di (2-ethylhexyl) phthalate (DEHP) has immunotoxic effects on both the expression of surface molecules (CD3, CD4, CD8 and CD28) on T cells of the thymus and spleen in male C57BL/6 mice.</p><p><b>METHODS</b>Animals were orally administered a 0.1% or 0.2% DEHP-containing diet for 10 or 20 days. Dietary corn oil was used as the vehicle for DEHP in preparing the diet.</p><p><b>RESULTS</b>Significant hepatic hypertrophy was clearly observed in the DEHP-exposed groups, while no atrophy was seen in the thymus or spleen in any treatment groups. In the thymus and spleen, no variation in the proportions of both T cells expressing CD3, CD4 and CD8 was shown with cytometry analysis. The surface expression of CD3, CD4, CD8 and CD28 on both T cells was also invariable in all analyzed stages of thymic differentiation and in the spleen. No effect of DEHP on mitogenesis was shown in the splenic T cells with anin vitro [(3)H]-thymidine-incorporation technique.</p><p><b>CONCLUSIONS</b>DEHP is probably not an immunosuppressor, particularly for T cells.</p>